ï»¿<!DOCTYPE html ><html><body><div>S-0338.1</div><hr style="margin-left:1.25in;margin-right:1.25in;height:1px;color:#333;" /><div style="font-weight:bold;text-align:center;">SENATE BILL 5324</div><hr style="margin-left:1.25in;margin-right:1.25in;height:1px;color:#333;" /><table style="width:622px;margin-top:0.1in;"><tr><td><div style="font-weight:bold;">State of Washington</div></td><td><div style="font-weight:bold;">69th Legislature</div></td><td><div style="font-weight:bold;">2025 Regular Session</div></td></tr></table><div style="margin-top:0.1in;"><span style="font-weight:bold;margin-right:0.25in;">By</span><!-- field: Sponsors -->Senators Cleveland, Muzzall, Nobles, and Slatter<!-- field: --></div><div style="margin-top:0.1in;"><span style="margin-right:0.25in;">Read first time 01/17/25.</span><span style="margin-right:0.25in;">Referred to Committee on Health &amp; Long-Term Care.</span></div><div style="text-indent:0.5in;margin-top:0.5in;"><!-- field: CaptionsTitles -->AN ACT Relating to aligning the implementation of application programming interfaces for prior authorization with federal guidelines; and amending RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.830'>48.43.830</a>,  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=41.05.845'>41.05.845</a>, and  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=74.09.840'>74.09.840</a>.<!-- field: --></div><div style="margin-top:0.25in;margin-bottom:0.25in;">BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:</div><div style="margin-top:0.25in;text-indent:0.5in;"><!-- field: BeginningSection --><span style="font-weight:bold;padding-right:0.1in;">Sec. 1.  </span>RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.830'>48.43.830</a> and 2023 c 382 s 1 are each amended to read as follows:<!-- field: --></div><div style="text-indent:0.5in;"><!-- field: Text -->(1) Each carrier offering a health plan issued or renewed on or after January 1, 2024, shall comply with the following standards related to prior authorization for health care services and prescription drugs:</div><div style="text-indent:0.5in;">(a) The carrier shall meet the following time frames for prior authorization determinations and notifications to a participating provider or facility that submits the prior authorization request through an electronic prior authorization process, as designated by each carrier:</div><div style="text-indent:0.5in;">(i) For electronic standard prior authorization requests, the carrier shall make a decision and notify the provider or facility of the results of the decision within three calendar days, excluding holidays, of submission of an electronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the carrier to make a decision, the carrier shall request any additional information from the provider or facility within one calendar day of submission of the electronic prior authorization request.</div><div style="text-indent:0.5in;">(ii) For electronic expedited prior authorization requests, the carrier shall make a decision and notify the provider or facility of the results of the decision within one calendar day of submission of an electronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the carrier to make a decision, the carrier shall request any additional information from the provider or facility within one calendar day of submission of the electronic prior authorization request.</div><div style="text-indent:0.5in;">(b) The carrier shall meet the following time frames for prior authorization determinations and notifications to a participating provider or facility that submits the prior authorization request through a process other than an electronic prior authorization process:</div><div style="text-indent:0.5in;">(i) For nonelectronic standard prior authorization requests, the carrier shall make a decision and notify the provider or facility of the results of the decision within five calendar days of submission of a nonelectronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the carrier to make a decision, the carrier shall request any additional information from the provider or facility within five calendar days of submission of the nonelectronic prior authorization request.</div><div style="text-indent:0.5in;">(ii) For nonelectronic expedited prior authorization requests, the carrier shall make a decision and notify the provider or facility of the results of the decision within two calendar days of submission of a nonelectronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the carrier to make a decision, the carrier shall request any additional information from the provider or facility within one calendar day of submission of the nonelectronic prior authorization request.</div><div style="text-indent:0.5in;">(c) In any instance in which a carrier has determined that a provider or facility has not provided sufficient information for making a determination under (a) and (b) of this subsection, a carrier may establish a specific reasonable time frame for submission of the additional information. This time frame must be communicated to the provider and enrollee with a carrier's request for additional information.</div><div style="text-indent:0.5in;">(d) The carrier's prior authorization requirements must be described in detail and written in easily understandable language. The carrier shall make its most current prior authorization requirements and restrictions, including the written clinical review criteria, available to providers and facilities in an electronic format upon request. The prior authorization requirements must be based on peer-reviewed clinical review criteria. The clinical review criteria must be evidence-based criteria and must accommodate new and emerging information related to the appropriateness of clinical criteria with respect to black and indigenous people, other people of color, gender, and underserved populations. The clinical review criteria must be evaluated and updated, if necessary, at least annually.</div><div style="text-indent:0.5in;">(2)(a) Each carrier shall ((<span style="text-decoration:line-through;">build and maintain a prior authorization application programming interface that automates the process for in-network providers to determine whether a prior authorization is required for health care services, identify prior authorization information and documentation requirements, and facilitate the exchange of prior authorization requests and determinations from its electronic health records or practice management system. The application programming interface must support the exchange of prior authorization requests and determinations for health care services beginning January 1, 2025, and must:</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(i) Use health level 7 fast health care interoperability resources in accordance with standards and provisions defined in 45 C.F.R. Sec. 170.215 and 45 C.F.R. Sec. 156.22(3)(b);</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(ii) Automate the process to determine whether a prior authorization is required for durable medical equipment or a health care service;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iii) Allow providers to query the carrier's prior authorization documentation requirements;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iv) Support an automated approach using nonproprietary open workflows to compile and exchange the necessary data elements to populate the prior authorization requirements that are compliant with the federal health insurance portability and accountability act of 1996 or have an exception from the federal centers for medicare and medicaid services; and</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(v) Indicate that</span>))<span style="text-decoration:underline;">establish and maintain a prior authorization application programming interface that is consistent with final rules issued by the federal centers for medicare and medicaid services and published in the federal register, and that indicates that</span> a prior authorization denial or authorization of a service less intensive than that included in the original request is an adverse benefit determination and is subject to the carrier's grievance and appeal process under RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.535'>48.43.535</a>. <span style="text-decoration:underline;">The implementation of the application programming interface must align with federal effective dates, including enforcement delays and suspensions, issued by the federal centers for medicare and medicaid services.</span></div><div style="text-indent:0.5in;">(b) Each carrier shall establish and maintain an interoperable electronic process or application programming interface that automates the process for in-network providers to determine whether a prior authorization is required for a covered prescription drug. The <span style="text-decoration:underline;">interoperable electronic process or</span> application programming interface must support the exchange of prior authorization requests and determinations for prescription drugs, including information on covered alternative prescription drugs, beginning January 1, 2027, and must:</div><div style="text-indent:0.5in;">(i) Allow providers to identify prior authorization information and documentation requirements;</div><div style="text-indent:0.5in;">(ii) Facilitate the exchange of prior authorization requests and determinations from its electronic health records or practice management system((<span style="text-decoration:line-through;">, and may include the necessary data elements to populate the prior authorization requirements that are compliant with the federal health insurance portability and accountability act of 1996 or have an exception from the federal centers for medicare and medicaid services</span>)); and</div><div style="text-indent:0.5in;">(iii) Indicate that a prior authorization denial or authorization of a drug other than the one included in the original prior authorization request is an adverse benefit determination and is subject to the carrier's grievance and appeal process under RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.535'>48.43.535</a>.</div><div style="text-indent:0.5in;">(c) If federal rules related to standards for using an application programming interface to communicate prior authorization status to providers are not finalized by the federal centers for medicare and medicaid services by September 13, 2023, the requirements of (a) of this subsection may not be enforced until ((<span style="text-decoration:line-through;">January 1, 2026</span>))<span style="text-decoration:underline;">final rules published by the federal government take effect</span>.</div><div style="text-indent:0.5in;">(d)((<span style="text-decoration:line-through;">(i) If a carrier determines that it will not be able to satisfy the requirements of (a) of this subsection by January 1, 2025, the carrier shall submit a narrative justification to the commissioner on or before September 1, 2024, describing:</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(A) The reasons that the carrier cannot reasonably satisfy the requirements;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(B) The impact of noncompliance upon providers and enrollees;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(C) The current or proposed means of providing health information to the providers; and</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(D) A timeline and implementation plan to achieve compliance with the requirements.</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(ii) The commissioner may grant a one-year delay in enforcement of the requirements of (a) of this subsection (2) if the commissioner determines that the carrier has made a good faith effort to comply with the requirements.</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iii) This subsection (2)(d) shall not apply if the delay in enforcement in (c) of this subsection takes effect because the federal centers for medicare and medicaid services did not finalize the applicable regulations by September 13, 2023.</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(e)</span>)) By September 13, 2023, and at least every six months thereafter until September 13, 2026, the commissioner shall provide an update to the health care policy committees of the legislature on the development of rules and implementation guidance from the federal centers for medicare and medicaid services regarding the standards for development of application programming interfaces and interoperable electronic processes related to prior authorization functions. The updates should include recommendations, as appropriate, on whether the status of the federal rule development aligns with the provisions of chapter 382, Laws of 2023. The commissioner also shall report on any actions by the federal centers for medicare and medicaid services to exercise enforcement discretion related to the implementation and maintenance of an application programming interface for prior authorization functions. The commissioner shall consult with the health care authority, carriers, providers, and consumers on the development of these updates and any recommendations.</div><div style="text-indent:0.5in;">(3) Nothing in this section applies to prior authorization determinations made pursuant to RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.761'>48.43.761</a>.</div><div style="text-indent:0.5in;">(4) For the purposes of this section:</div><div style="text-indent:0.5in;">(a) "Expedited prior authorization request" means a request by a provider or facility for approval of a health care service or prescription drug where:</div><div style="text-indent:0.5in;">(i) The passage of time:</div><div style="text-indent:0.5in;">(A) Could seriously jeopardize the life or health of the enrollee;</div><div style="text-indent:0.5in;">(B) Could seriously jeopardize the enrollee's ability to regain maximum function; or</div><div style="text-indent:0.5in;">(C) In the opinion of a provider or facility with knowledge of the enrollee's medical condition, would subject the enrollee to severe pain that cannot be adequately managed without the health care service or prescription drug that is the subject of the request; or</div><div style="text-indent:0.5in;">(ii) The enrollee is undergoing a current course of treatment using a nonformulary drug.</div><div style="text-indent:0.5in;">(b) "Standard prior authorization request" means a request by a provider or facility for approval of a health care service or prescription drug where the request is made in advance of the enrollee obtaining a health care service or prescription drug that is not required to be expedited.<!-- field: --></div><!-- field: --><div style="margin-top:0.25in;text-indent:0.5in;"><!-- field: BeginningSection --><span style="font-weight:bold;padding-right:0.1in;">Sec. 2.  </span>RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=41.05.845'>41.05.845</a> and 2023 c 382 s 2 are each amended to read as follows:<!-- field: --></div><div style="text-indent:0.5in;"><!-- field: Text -->(1) A health plan offered to public employees, retirees, and their covered dependents under this chapter issued or renewed on or after January 1, 2024, shall comply with the following standards related to prior authorization for health care services and prescription drugs:</div><div style="text-indent:0.5in;">(a) The health plan shall meet the following time frames for prior authorization determinations and notifications to a participating provider or facility that submits the prior authorization request through an electronic prior authorization process:</div><div style="text-indent:0.5in;">(i) For electronic standard prior authorization requests, the health plan shall make a decision and notify the provider or facility of the results of the decision within three calendar days, excluding holidays, of submission of an electronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the health plan to make a decision, the health plan shall request any additional information from the provider or facility within one calendar day of submission of the electronic prior authorization request.</div><div style="text-indent:0.5in;">(ii) For electronic expedited prior authorization requests, the health plan shall make a decision and notify the provider or facility of the results of the decision within one calendar day of submission of an electronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the health plan to make a decision, the health plan shall request any additional information from the provider or facility within one calendar day of submission of the electronic prior authorization request.</div><div style="text-indent:0.5in;">(b) The health plan shall meet the following time frames for prior authorization determinations and notifications to a participating provider or facility that submits the prior authorization request through a process other than an electronic prior authorization process described in subsection (2) of this section:</div><div style="text-indent:0.5in;">(i) For nonelectronic standard prior authorization requests, the health plan shall make a decision and notify the provider or facility of the results of the decision within five calendar days of submission of a nonelectronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the health plan to make a decision, the health plan shall request any additional information from the provider or facility within five calendar days of submission of the nonelectronic prior authorization request.</div><div style="text-indent:0.5in;">(ii) For nonelectronic expedited prior authorization requests, the health plan shall make a decision and notify the provider or facility of the results of the decision within two calendar days of submission of a nonelectronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the health plan to make a decision, the health plan shall request any additional information from the provider or facility within one calendar day of submission of the nonelectronic prior authorization request.</div><div style="text-indent:0.5in;">(c) In any instance in which the health plan has determined that a provider or facility has not provided sufficient information for making a determination under (a) and (b) of this subsection, the health plan may establish a specific reasonable time frame for submission of the additional information. This time frame must be communicated to the provider and enrollee with the health plan's request for additional information.</div><div style="text-indent:0.5in;">(d) The prior authorization requirements of the health plan must be described in detail and written in easily understandable language. The health plan shall make its most current prior authorization requirements and restrictions, including the written clinical review criteria, available to providers and facilities in an electronic format upon request. The prior authorization requirements must be based on peer-reviewed clinical review criteria. The clinical review criteria must be evidence-based criteria and must accommodate new and emerging information related to the appropriateness of clinical criteria with respect to black and indigenous people, other people of color, gender, and underserved populations. The clinical review criteria must be evaluated and updated, if necessary, at least annually.</div><div style="text-indent:0.5in;">(2)(a) Each health plan offered to public employees, retirees, and their covered dependents under this chapter shall ((<span style="text-decoration:line-through;">build and maintain a prior authorization application programming interface that automates the process for in-network providers to determine whether a prior authorization is required for health care services, identify prior authorization information and documentation requirements, and facilitate the exchange of prior authorization requests and determinations from its electronic health records or practice management system. The application programming interface must support the exchange of prior authorization requests and determinations for health care services beginning January 1, 2025, and must:</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(i) Use health level 7 fast health care interoperability resources in accordance with standards and provisions defined in 45 C.F.R. Sec. 170.215 and 45 C.F.R. Sec. 156.22(3)(b);</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(ii) Automate the process to determine whether a prior authorization is required for durable medical equipment or a health care service;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iii) Allow providers to query the health plan's prior authorization documentation requirements;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iv) Support an automated approach using nonproprietary open workflows to compile and exchange the necessary data elements to populate the prior authorization requirements that are compliant with the federal health insurance portability and accountability act of 1996 or have an exception from the federal centers for medicare and medicaid services; and</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(v) Indicate that</span>))<span style="text-decoration:underline;">establish and maintain a prior authorization application programming interface that is consistent with final rules issued by the federal centers for medicare and medicaid services and published in the federal register, and that indicates that</span> a prior authorization denial or authorization of a service less intensive than that included in the original request is an adverse benefit determination and is subject to the health plan's grievance and appeal process under RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.535'>48.43.535</a>. <span style="text-decoration:underline;">The implementation of the application programming interface must align with federal effective dates, including enforcement delays and suspensions, issued by the federal centers for medicare and medicaid services.</span></div><div style="text-indent:0.5in;">(b) Each health plan offered to public employees, retirees, and their covered dependents under this chapter shall establish and maintain an interoperable electronic process or application programming interface that automates the process for in-network providers to determine whether a prior authorization is required for a covered prescription drug. The <span style="text-decoration:underline;">interoperable electronic process or</span> application programming interface must support the exchange of prior authorization requests and determinations for prescription drugs, including information on covered alternative prescription drugs, beginning January 1, 2027, and must:</div><div style="text-indent:0.5in;">(i) Allow providers to identify prior authorization information and documentation requirements;</div><div style="text-indent:0.5in;">(ii) Facilitate the exchange of prior authorization requests and determinations from its electronic health records or practice management system((<span style="text-decoration:line-through;">, and may include the necessary data elements to populate the prior authorization requirements that are compliant with the federal health insurance portability and accountability act of 1996 or have an exception from the federal centers for medicare and medicaid services</span>)); and</div><div style="text-indent:0.5in;">(iii) Indicate that a prior authorization denial or authorization of a drug other than the one included in the original prior authorization request is an adverse benefit determination and is subject to the health plan's grievance and appeal process under RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.535'>48.43.535</a>.</div><div style="text-indent:0.5in;">(c) If federal rules related to standards for using an application programming interface to communicate prior authorization status to providers are not finalized by the federal centers for medicare and medicaid services by September 13, 2023, the requirements of (a) of this subsection may not be enforced until ((<span style="text-decoration:line-through;">January 1, 2026</span>))<span style="text-decoration:underline;">final rules published by the federal government take effect</span>.</div><div style="text-indent:0.5in;">((<span style="text-decoration:line-through;">(d)(i) If the health plan determines that it will not be able to satisfy the requirements of (a) of this subsection by January 1, 2025, the health plan shall submit a narrative justification to the authority on or before September 1, 2024, describing:</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(A) The reasons that the health plan cannot reasonably satisfy the requirements;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(B) The impact of noncompliance upon providers and enrollees;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(C) The current or proposed means of providing health information to the providers; and</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(D) A timeline and implementation plan to achieve compliance with the requirements.</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(ii) The authority may grant a one-year delay in enforcement of the requirements of (a) of this subsection (2) if the authority determines that the health plan has made a good faith effort to comply with the requirements.</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iii) This subsection (2)(d) shall not apply if the delay in enforcement in (c) of this subsection takes effect because the federal centers for medicare and medicaid services did not finalize the applicable regulations by September 13, 2023.</span>))</div><div style="text-indent:0.5in;">(3) Nothing in this section applies to prior authorization determinations made pursuant to RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=41.05.526'>41.05.526</a>.</div><div style="text-indent:0.5in;">(4) For the purposes of this section:</div><div style="text-indent:0.5in;">(a) "Expedited prior authorization request" means a request by a provider or facility for approval of a health care service or prescription drug where:</div><div style="text-indent:0.5in;">(i) The passage of time:</div><div style="text-indent:0.5in;">(A) Could seriously jeopardize the life or health of the enrollee;</div><div style="text-indent:0.5in;">(B) Could seriously jeopardize the enrollee's ability to regain maximum function; or</div><div style="text-indent:0.5in;">(C) In the opinion of a provider or facility with knowledge of the enrollee's medical condition, would subject the enrollee to severe pain that cannot be adequately managed without the health care service or prescription drug that is the subject of the request; or</div><div style="text-indent:0.5in;">(ii) The enrollee is undergoing a current course of treatment using a nonformulary drug.</div><div style="text-indent:0.5in;">(b) "Standard prior authorization request" means a request by a provider or facility for approval of a health care service or prescription drug where the request is made in advance of the enrollee obtaining a health care service that is not required to be expedited.</div><div style="text-indent:0.5in;">(5) This section shall not apply to coverage provided under the medicare part C or part D programs set forth in Title XVIII of the social security act of 1965, as amended.<!-- field: --></div><!-- field: --><div style="margin-top:0.25in;text-indent:0.5in;"><!-- field: BeginningSection --><span style="font-weight:bold;padding-right:0.1in;">Sec. 3.  </span>RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=74.09.840'>74.09.840</a> and 2023 c 382 s 3 are each amended to read as follows:<!-- field: --></div><div style="text-indent:0.5in;"><!-- field: Text -->(1) Beginning January 1, 2024, the authority shall require each managed care organization to comply with the following standards related to prior authorization for health care services and prescription drugs:</div><div style="text-indent:0.5in;">(a) The managed care organization shall meet the following time frames for prior authorization determinations and notifications to a participating provider or facility that submits the prior authorization request through an electronic prior authorization process, as designated by each managed care organization:</div><div style="text-indent:0.5in;">(i) For electronic standard prior authorization requests, the managed care organization shall make a decision and notify the provider or facility of the results of the decision within three calendar days, excluding holidays, of submission of an electronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the managed care organization to make a decision, the managed care organization shall request any additional information from the provider or facility within one calendar day of submission of the electronic prior authorization request.</div><div style="text-indent:0.5in;">(ii) For electronic expedited prior authorization requests, the managed care organization shall make a decision and notify the provider or facility of the results of the decision within one calendar day of submission of an electronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the managed care organization to make a decision, the managed care organization shall request any additional information from the provider or facility within one calendar day of submission of the electronic prior authorization request.</div><div style="text-indent:0.5in;">(b) The managed care organization shall meet the following time frames for prior authorization determinations and notifications to a participating provider or facility that submits the prior authorization request through a process other than an electronic prior authorization process described in subsection (2) of this section:</div><div style="text-indent:0.5in;">(i) For nonelectronic standard prior authorization requests, the managed care organization shall make a decision and notify the provider or facility of the results of the decision within five calendar days of submission of a nonelectronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the managed care organization to make a decision, the managed care organization shall request any additional information from the provider or facility within five calendar days of submission of the nonelectronic prior authorization request.</div><div style="text-indent:0.5in;">(ii) For nonelectronic expedited prior authorization requests, the managed care organization shall make a decision and notify the provider or facility of the results of the decision within two calendar days of submission of a nonelectronic prior authorization request by the provider or facility that contains the necessary information to make a determination. If insufficient information has been provided to the managed care organization to make a decision, the managed care organization shall request any additional information from the provider or facility within one calendar day of submission of the nonelectronic prior authorization request.</div><div style="text-indent:0.5in;">(c) In any instance in which a managed care organization has determined that a provider or facility has not provided sufficient information for making a determination under (a) and (b) of this subsection, a managed care organization may establish a specific reasonable time frame for submission of the additional information. This time frame must be communicated to the provider and enrollee with a managed care organization's request for additional information.</div><div style="text-indent:0.5in;">(d) The prior authorization requirements of the managed care organization must be described in detail and written in easily understandable language. The managed care organization shall make its most current prior authorization requirements and restrictions, including the written clinical review criteria, available to providers and facilities in an electronic format upon request. The prior authorization requirements must be based on peer-reviewed clinical review criteria. The clinical review criteria must be evidence-based criteria and must accommodate new and emerging information related to the appropriateness of clinical criteria with respect to black and indigenous people, other people of color, gender, and underserved populations. The clinical review criteria must be evaluated and updated, if necessary, at least annually.</div><div style="text-indent:0.5in;">(2)(a) Each managed care organization shall ((<span style="text-decoration:line-through;">build and maintain a prior authorization application programming interface that automates the process for in-network providers to determine whether a prior authorization is required for health care services, identify prior authorization information and documentation requirements, and facilitate the exchange of prior authorization requests and determinations from its electronic health records or practice management system. The application programming interface must support the exchange of prior authorization requests and determinations for health care services beginning January 1, 2025, and must:</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(i) Use health level 7 fast health care interoperability resources in accordance with standards and provisions defined in 45 C.F.R. Sec. 170.215 and 45 C.F.R. Sec. 156.22(3)(b);</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(ii) Automate the process to determine whether a prior authorization is required for durable medical equipment or a health care service;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iii) Allow providers to query the managed care organization's prior authorization documentation requirements;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iv) Support an automated approach using nonproprietary open workflows to compile and exchange the necessary data elements to populate the prior authorization requirements that are compliant with the federal health insurance portability and accountability act of 1996 or have an exception from the federal centers for medicare and medicaid services; and</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(v) Indicate that</span>))<span style="text-decoration:underline;">establish and maintain a prior authorization application programming interface that is consistent with final rules issued by the federal centers for medicare and medicaid services and published in the federal register, and that indicates that</span> a prior authorization denial or authorization of a service less intensive than that included in the original request is an adverse benefit determination and is subject to the managed care organization's grievance and appeal process under RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.535'>48.43.535</a>. <span style="text-decoration:underline;">The implementation of the application programming interface must align with federal effective dates, including enforcement delays and suspensions, issued by the federal centers for medicare and medicaid services.</span></div><div style="text-indent:0.5in;">(b) Each managed care organization shall establish and maintain an interoperable electronic process or application programming interface that automates the process for in-network providers to determine whether a prior authorization is required for a covered prescription drug. The <span style="text-decoration:underline;">interoperable electronic process or</span> application programming interface must support the exchange of prior authorization requests and determinations for prescription drugs, including information on covered alternative prescription drugs, beginning January 1, 2027, and must:</div><div style="text-indent:0.5in;">(i) Allow providers to identify prior authorization information and documentation requirements;</div><div style="text-indent:0.5in;">(ii) Facilitate the exchange of prior authorization requests and determinations from its electronic health records or practice management system((<span style="text-decoration:line-through;">, and may include the necessary data elements to populate the prior authorization requirements that are compliant with the federal health insurance portability and accountability act of 1996 or have an exception from the federal centers for medicare and medicaid services</span>)); and</div><div style="text-indent:0.5in;">(iii) Indicate that a prior authorization denial or authorization of a drug other than the one included in the original prior authorization request is an adverse benefit determination and is subject to the managed care organization's grievance and appeal process under RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=48.43.535'>48.43.535</a>.</div><div style="text-indent:0.5in;">(c) If federal rules related to standards for using an application programming interface to communicate prior authorization status to providers are not finalized by September 13, 2023, the requirements of (a) of this subsection may not be enforced until ((<span style="text-decoration:line-through;">January 1, 2026</span>))<span style="text-decoration:underline;">final rules published by the federal government take effect</span>.</div><div style="text-indent:0.5in;">((<span style="text-decoration:line-through;">(d)(i) If a managed care organization determines that it will not be able to satisfy the requirements of (a) of this subsection by January 1, 2025, the managed care organization shall submit a narrative justification to the authority on or before September 1, 2024, describing:</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(A) The reasons that the managed care organization cannot reasonably satisfy the requirements;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(B) The impact of noncompliance upon providers and enrollees;</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(C) The current or proposed means of providing health information to the providers; and</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(D) A timeline and implementation plan to achieve compliance with the requirements.</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(ii) The authority may grant a one-year delay in enforcement of the requirements of (a) of this subsection (2) if the authority determines that the managed care organization has made a good faith effort to comply with the requirements.</span></div><div style="text-indent:0.5in;"><span style="text-decoration:line-through;">(iii) This subsection (2)(d) shall not apply if the delay in enforcement in (c) of this subsection takes effect because the federal centers for medicare and medicaid services did not finalize the applicable regulations by September 13, 2023.</span>))</div><div style="text-indent:0.5in;">(3) Nothing in this section applies to prior authorization determinations made pursuant to RCW  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=71.24.618'>71.24.618</a> or  <a href='http://app.leg.wa.gov/RCW/default.aspx?cite=74.09.490'>74.09.490</a>.</div><div style="text-indent:0.5in;">(4) For the purposes of this section:</div><div style="text-indent:0.5in;">(a) "Expedited prior authorization request" means a request by a provider or facility for approval of a health care service or prescription drug where:</div><div style="text-indent:0.5in;">(i) The passage of time:</div><div style="text-indent:0.5in;">(A) Could seriously jeopardize the life or health of the enrollee;</div><div style="text-indent:0.5in;">(B) Could seriously jeopardize the enrollee's ability to regain maximum function; or</div><div style="text-indent:0.5in;">(C) In the opinion of a provider or facility with knowledge of the enrollee's medical condition, would subject the enrollee to severe pain that cannot be adequately managed without the health care service or prescription drug that is the subject of the request; or</div><div style="text-indent:0.5in;">(ii) The enrollee is undergoing a current course of treatment using a nonformulary drug.</div><div style="text-indent:0.5in;">(b) "Standard prior authorization request" means a request by a provider or facility for approval of a health care service or prescription drug where the request is made in advance of the enrollee obtaining a health care service or prescription drug that is not required to be expedited.<!-- field: --></div><!-- field: --><div style="margin-top:0.1in;font-weight:bold;text-align:center;">--- END ---</div></body></html>